Skip to Content

Tilray Brands Inc

TLRY: XTSE (CAN)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
CAD 9.50XjfZdflrzx

Tilray Earnings: Slower Fiscal Period Than We Expected, but Second Half of Year Should Be Better

Based on our initial review of no-moat Tilray’s fiscal second-quarter results, we expect to trim our full-year revenue forecast by a mid-single-digit percentage. This is mostly due to slightly slower cannabis revenue growth than we expected as Canada remains overcrowded with licensed producers. This should lead to a mid-single-digit percentage reduction in our fair value estimates of $3.30 and CAD 4.50 per share. As reflected in our Very High Uncertainty rating for the company, changes to our forecasts can have dramatic effects on our fair value estimates. Tilray has yet to achieve positive free cash flow and the potential for equity dilution to fund cash burn underpins the risk that drives our uncertainty rating.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of TLRY so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center